Detalhe da pesquisa
1.
Interferon lambda 4 genotype and pathway in alcoholic hepatitis.
Scand J Gastroenterol
; 56(3): 304-311, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33602032
2.
Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH.
Int J Mol Sci
; 22(12)2021 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34199317
3.
Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH.
BMC Gastroenterol
; 19(1): 228, 2019 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31883514
4.
Measurement of matrix metalloproteinase 9-mediated collagen type III degradation fragment as a marker of skin fibrosis.
BMC Dermatol
; 11: 6, 2011 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-21447148
5.
Activation of thyroid hormone receptor-ß improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis.
Br J Pharmacol
; 178(12): 2412-2423, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33655500
6.
The Selective Peroxisome Proliferator-Activated Receptor Gamma Modulator CHS-131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis.
Hepatol Commun
; 4(9): 1302-1315, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923834
7.
Low Interleukin-22 Binding Protein Is Associated With High Mortality in Alcoholic Hepatitis and Modulates Interleukin-22 Receptor Expression.
Clin Transl Gastroenterol
; 11(8): e00197, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32955203
8.
Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy.
World J Hepatol
; 8(16): 673-84, 2016 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27326314
9.
Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases.
Fibrogenesis Tissue Repair
; 6(1): 9, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23635022
10.
Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model.
BMC Res Notes
; 5(1): 686, 2012 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23249435
11.
Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology.
Am J Transl Res
; 4(4): 403-14, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23145208
12.
MMP mediated degradation of type VI collagen is highly associated with liver fibrosis--identification and validation of a novel biochemical marker assay.
PLoS One
; 6(9): e24753, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21935455
13.
Measurement of CO3-610, a potential liver biomarker derived from matrix metalloproteinase-9 degradation of collagen type iii, in a rat model of reversible carbon-tetrachloride-induced fibrosis.
Biomark Insights
; 6: 49-58, 2011 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21499440
14.
Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats.
Fibrogenesis Tissue Repair
; 3(1): 5, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20359335
15.
Serum markers of liver fibrosis: combining the BIPED classification and the neo-epitope approach in the development of new biomarkers.
Dis Markers
; 28(1): 15-28, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20164543